NAD(P)H oxidase polymorphism (C242T) and high HDL cholesterol associate with recurrent coronary events in postinfarction patients

Atherosclerosis

Volumn 196, Issue 1, 2008, Pages 461-468

  Corsetti, James P ^a   Ryan, Dan ^a   Moss, Arthur J ^a   Zareba, Wojciech ^a   Sparks, Charles E ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

C242T polymorphism; HDL; Oxidative stress; p22phox; Recurrent coronary risk; Vascular NAD(P)H oxidase

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PROTEIN P22; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ADULT; ALLELE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GENOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

C-REACTIVE PROTEIN; CHOLESTEROL, HDL; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NADPH OXIDASE; OXIDATIVE STRESS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECURRENCE;

EID: 38049087505     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.12.007     Document Type: Article

References (27)

1. Corsetti J.P., Zareba W., Moss A.J., et al. Elevated HDL is a risk factor for recurrent coronary events in a subgroup of non-diabetic postinfarction patients with hypercholesterolemia and inflammation. Atherosclerosis 187 (2006) 191-197
2. Corsetti J.P., Zareba W., Moss A.J., and Sparks C.E. Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patients. Atherosclerosis 183 (2005) 293-300
3. Barter P.J., Nicholls S., Rye K.A., et al. Antiinflammatory properties of HDL. Circ Res 95 (2004) 764-772
4. Ansell B.J., Watson K.E., Fogelman A.M., Navab M., and Fonarow G.C. High-density lipoprotein function: recent advances. J Am Coll Cardiol 46 (2005) 1792-1798
5. Navab M., Ananthramaiah G.M., Reddy S.T., et al. The double jeopardy of HDL. Ann Med 37 (2005) 173-178
6. Harrison D., Griendling K.K., Landmesser U., Hornig B., and Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 91 Suppl. (2003) 7A-11A
7. Soccio M., Toniato E., Evangelista V., Carluccio M., and De Caterina R. Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. Eur J Clin Invest 35 (2005) 305-314
8. Madamanchi N.R., Vendrov A., and Runge M.S. Oxidative stress and vascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 29-38
9. Guzik T.J., West N.E.J., Black E., et al. Functional effect of the C242T polymorphism in the NAD(P)H oxidase p22phox gene on vascular superoxide production in atherosclerosis. Circulation 102 (2000) 1744-1747
10. Nakano T., Matsunaga S., Nagata A., and Maruyama T. NAD(P)H oxidase p22phox gene C242T polymorphism and lipoprotein oxidation. Clin Chim Acta 335 (2003) 101-107
11. Moss A.J., Goldstein R.E., Marder V.J., et al. Thrombogenic factors and recurrent coronary events. Circulation 99 (1999) 2517-2522
12. Rainwater D.L. Electrophoretic separation of LDL and HDL subclasses. Methods Mol Biol 110 (1998) 137-151
13. Shimoni N., Kaplan M., and Keidar S. Cardiovascular diseases in patients with high levels of plasma high density lipoprotein: association with increased plasma oxidative state. Israel Med Ass J 5 (2003) 702-705.6
14. Moss A.J., Ryan D., Oakes D., et al. Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction. Am J Cardiol 96 (2005) 177-182
15. Ansell B.J., Navab M., Hama S., et al. Inflammatory/anti-inflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment. Circulation 108 (2003) 2751-2756
16. Shimokata K., Yamada Y., Kondo T., et al. Association of gene polymorphisms with coronary artery disease in individuals with or without nonfamilial hypercholesterolemia. Atherosclerosis 172 (2004) 167-173
17. Inoue N., Kawashima S., Kanazawa K., et al. Polymorphism of the NADH/NADPH oxidase p22phox gene in patients with coronary artery disease. Circulation 97 (1998) 135-137
18. Wolin M.S. How could a genetic variant of the p22phox component of NAD(P)H oxidases contribute to the progression of coronary atherosclerosis?. Circ Res 86 (2000) 365-366
19. Zheng L., Nukuna B., Brennan M.L., et al. Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J Clin Invest 114 (2004) 529-541
20. Bergt C., Pennathur S., Fu X., et al. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABC A1-dependent cholesterol transport. PNAS 101 (2004) 13032-13037
21. Pennathur S., Bergt C., Shao B., et al. Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. J Biol Chem 279 (2004) 42977-42983
22. Zhang C., Yang J., Jacobs D., and Jennings L.K. Interaction of myeloperoxidase with vascular NAD(P)H oxidase-derived reactive oxygen species in vasculature: implications for vascular diseases. Am J Physiol Heart Circ Physiol 285 (2003) H2563-H2572
23. Lewis G.F., and Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96 (2005) 1221-1232
24. Marsche G., Hammer A., Oskolkova O., et al. Hypochlorite- modified high density lipoprotein; a high affinity ligand to scavenger receptor class B, type I, impairs high density lipoprotein-dependent selective lipid uptake and reverse cholesterol transport. J Biol Chem 277 (2002) 32172-32179
25. Syvanne M., Ahola M., Lahdenpera S., et al. High density lipoprotein subfraction in non-insulin-dependent diabetes mellitus and coronary artery disease. J Lipid Res 36 (1995) 573-582
26. Bhalodkar N., Blum S., Rana T., et al. Comparison of levels of large and small high-density lipoprotein cholesterol in Asian Indian men compared with Caucasian men in the Framingham Offspring Study. Am J Cardiol 94 (2004) 1561-1563
27. Freedman D.S., Otvos J.D., Jeyarajah E.J., et al. Sex and age differences in lipoprotein subclasses measured by nuclear magnetic resonance spectroscopy: the Framingham Study. Clin Chem 50 (2004) 1189-1200